Please login to the form below

Not currently logged in
Email:
Password:

UCB's Steve Arnold joins ABPI board

Will work to support life sciences in the UK

Steve Arnold joins UCB from GileadThe Association for the British Pharmaceutical Industry (ABPI has appointed UCB's Steve Arnold to its board of management.

Arnold joined UCB in May this year as managing director of the British and Irish Isles folliwng a spell in Canada working for Gilead Sciences.

He will serve as board member of the ABPPI – the UK's trade body for the pharma industry – up to 2014.

“As a leading UK pharma investor, UCB believes that harnessing this scientific innovation and increasing our R&D focus is key to improving the UK's future prosperity and as a member of the ABPI's board of management I will be working to ensure that life sciences remain vibrant in the UK,” said Arnold.

“This is particularly important at such a challenging time for our industry when we are looking for the Government to provide the right fiscal, R&D and commercial environment for our industry to thrive.”

31st July 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics